Ubtech's Humanoid Sales Explode 1,445% — But the Market Is Still Weighing the Cost of Ambition

Ubtech Robotics' H1 2026 revenue doubled to 1.269B yuan, net loss narrowed, humanoid sales soared 1,445% YoY, but shares remain down 33% YTD.

The arithmetic of Ubtech Robotics' first half of 2026 is hard to ignore. Revenue more than doubled to roughly 1.269 billion yuan, a 104.2 percent jump from the 621.46 million yuan posted a year earlier, while the net loss narrowed to 311.48 million yuan from 413.65 million yuan. Loss per share improved to 0.62 yuan from 0.94 yuan. And in the headline metric that tends to grab attention in this corner of the market, sales of full-fledged humanoid robots soared 1,445 percent year on year.

Yet the share price response on Friday was measured rather than euphoric. The stock climbed 4.7 percent to 9.65 euros, adding to a 3.8 percent weekly gain and a 4.9 percent advance over 30 days. That still leaves the shares down 33 percent since the start of the year and well adrift of the 52-week high of 17.00 euros touched back in January.

The tension is easy to read. The interim figures, approved by the board and released through the Hong Kong exchange, paint a picture of a company finally getting its operational story straight — gross margin came in at 44.7 percent, costs are being reined in, and the loss is shrinking. But the market's longer-term verdict is still out on when, or whether, the red ink turns to black.

A Wider Net: Acquisitions, Alliances, and a Shareholder Stamp

The operational update came with strategic noise. Ubtech has acquired Zhejiang Fenglong Electric, a move the company frames as an expansion into new business areas beyond the core robotics franchise. Details on integration were thin, but the direction of travel — broadening the value chain — was unmistakable.

Shareholders also had their say. At an extraordinary general meeting in Shenzhen on Wednesday, four resolutions were approved, though the company did not publicly spell out their contents. The timing, coming days before the earnings release, suggests a housekeeping exercise ahead of a significant reporting period.

On the partnership front, Ubtech has struck a cooperation deal with semiconductor maker BASiC Semiconductor to jointly develop chip components for robotics applications — a logical hedge as humanoid volumes scale and the supply chain becomes a competitive battleground.

A Product Blitz and a Consumer Bet

The product pipeline has rarely looked fuller. At the World Robot Conference in Beijing last week, Ubtech unveiled a slate of new humanoid models: the Cruzr Y1 industrial robot, the Walker C1 service-oriented unit described by Reuters as a full humanoid built for interaction rather than factory work, and the "hyper-bionic" U1. The Walker S2 was also on display, bringing the total to four humanoid lines spanning customer service, logistics, manufacturing, and everyday use.

The consumer angle is gaining particular traction. The U1, marketed under the UWORLD brand, leans on technology previously developed for Airbus and Texas Instruments, and has already pulled in more than 2,100 pre-orders within a week of launch. The Cruzr Y1, meanwhile, comes equipped with a VLA model and Digua chips, targeting industrial clients.

The Competitive Scoreboard

Ubtech's numbers land in stark contrast to those of domestic rival Unitree, which recently listed in Shanghai. Unitree posted revenue of 11.52 million yuan in the same period, up 48.54 percent, and — notably — a net profit of 2.74 million yuan, albeit with a declining gross margin of 56.0 percent and rising R&D and sales costs. The two companies are heading in opposite financial directions: Ubtech grows faster but bleeds cash; Unitree grows slower but is already in the black.

The market has taken notice. Unitree's Shanghai debut raised roughly 900 million US dollars at a valuation near 9 billion US dollars, with the stock jumping 460 percent on day one. Ubtech, listed in Hong Kong, trades at a price-earnings ratio of 13.6 — a level many would call rich for a company still reporting losses.

State Support and a Reality Check

The macro backdrop for Chinese humanoid makers remains supportive. China accounted for around 90 percent of global humanoid robot deliveries in the first half of 2026, according to industry estimates. Government subsidies for the segment have been ratcheted up to 230 million US dollars for the first half of this year, up from 62 million US dollars a year earlier and just 6 million US dollars two years ago. Beijing is targeting production of more than 100,000 units in 2026, though Morgan Stanley's more conservative forecast sits at 50,000.

The sobering counterpoint comes from the factory floor. Reports indicate that Ubtech's Walker robots, deployed at contract manufacturers such as BYD and Foxconn, are currently operating at only 30 to 50 percent of human productivity levels. Impressive sales numbers, in other words, have yet to translate into machines that can fully hold their own alongside human workers.

For investors, the interim results offer a genuine improvement — faster growth, fatter margins, a narrower loss. But the persistent share price discount to the year's highs suggests the market is still pricing in execution risk, technical limitations, and the long road to profitability. The acquisition of Zhejiang Fenglong Electric and the BASiC Semiconductor tie-up signal a company determined to build beyond the robot itself. Whether that strategy converts into hard numbers is a question for the coming quarters.